Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK4083 in Moderately Active Ulcerative Colitis
NCT02647866Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Jun 2016
- Primary completion
- Sep 2018
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of rocatinlimab in ulcerative colitis (UC), sponsored by Kyowa Kirin. Started Jun 2016; status: completed.
02
Drugs
rocatinlimab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02647866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647866.